• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 497648 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414090728 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414090728 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Vanda Pharmaceuticals Trading Higher on 1.6x Above-Average Volume (VNDA)

Published on Fri, 05/10/2013 - 13:15
By Peter Chu

Vanda Pharmaceuticals's stock is up 1.6% to $5.14 on heavy trading volume. Today's volume of 371,000 shares tops the average 30-day volume of 232,000 shares. Spikes in volume can validate a breakout or signify a potential turning point.

Vanda Pharmaceuticals share prices have moved between a 52-week high of $5.17 and a 52-week low of $2.92 and are now trading 76% above that low price at $5.14 per share. The 200-day and 50-day moving averages have moved 0.23% higher and 2.04% higher over the past week, respectively.

Potential upside of 65.4% exists for Vanda Pharmaceuticals, based on a current level of $5.14 and analysts' average consensus price target of $8.50. The stock should find initial support at its 50-day moving average (MA) of $4.23 and further support at its 200-day MA of $3.96.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Advance Auto Parts: 52-Week High Recentl...

Advance Auto Parts (NYSE:AAP) traded today at a new 52-week high of $143.61. Approxima ...

Top 5 Performing Stocks in the S&P 500 (...

Below are the top five performing stocks in the S&P 500 INDEX,RTH. These companies shou ...

HMS Holdings Trading Higher on 1.2x Abov...

HMS Holdings shares are trading on heavy volume today, having risen 0.6% to $21.12. To ...

Shares of Lam Research Are Moving Higher...

Lam Research shares are trading on heavy volume today, having risen 5.7% to $75.96. To ...

Volume Spike Detected in Shares of StanC...

Shares of StanCorp Financial Group are trading today in above average volume, with the ...

Parker Hannifin Trading Higher on 1.2x A...

Shares of Parker Hannifin are trading up 6.7% to $116.50 today on above average volume. ...

Shares of Vimicro International Are Movi...

The price of Vimicro International shares has climbed to $9.71 (a 0.7% change) on heavy ...

Callidus Software's Shares Changing Hand...

Shares of Callidus Software are trading up 5.6% to $13.12 today on above average volume ...